Correlation Between NLS Pharmaceutics and Cingulate Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Cingulate Warrants, you can compare the effects of market volatilities on NLS Pharmaceutics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Cingulate Warrants.

Diversification Opportunities for NLS Pharmaceutics and Cingulate Warrants

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between NLS and Cingulate is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Cingulate Warrants go up and down completely randomly.

Pair Corralation between NLS Pharmaceutics and Cingulate Warrants

Assuming the 90 days horizon NLS Pharmaceutics is expected to generate 4.51 times less return on investment than Cingulate Warrants. But when comparing it to its historical volatility, NLS Pharmaceutics AG is 1.15 times less risky than Cingulate Warrants. It trades about 0.03 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  5.13  in Cingulate Warrants on December 28, 2024 and sell it today you would earn a total of  0.77  from holding Cingulate Warrants or generate 15.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy96.67%
ValuesDaily Returns

NLS Pharmaceutics AG  vs.  Cingulate Warrants

 Performance 
       Timeline  
NLS Pharmaceutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.
Cingulate Warrants 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

NLS Pharmaceutics and Cingulate Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NLS Pharmaceutics and Cingulate Warrants

The main advantage of trading using opposite NLS Pharmaceutics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.
The idea behind NLS Pharmaceutics AG and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Transaction History
View history of all your transactions and understand their impact on performance